JNJ Johnson & Johnson

  1. Stocks
  2. Healthcare
  3. NYSE: JNJ

Price (delayed)

$232.77

Market cap

$560.33B

P/E Ratio

26.66

Dividend/share

$5.24

EPS

$8.73

Enterprise value

$593.63B

?
Relative Growth: Rel. Growth: 65
Relative Strength: Rel. Strength: 69
Relative Valuation: Rel. Valuation: 36
Relative Profitability: Rel. Profitability: 88

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
JNJ's revenue is up by 8% year-on-year and by 2.3% since the previous quarter
The gross profit is up by 7% YoY and by 2.2% QoQ
JNJ's price to earnings (P/E) is 34% higher than its last 4 quarters average of 19.9 and 25% higher than its 5-year quarterly average of 21.3
The quick ratio has decreased by 28% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.jnj.com/
Peers: PFE MRK NVS SYK

Key stats

What are the main financial stats of JNJ

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
2.02%
1 week
3.3%
1 month
3.2%
1 year
51.48%
YTD
12.48%
QTD
-4.77%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$96.36B
Gross profit
$65.36B
Operating income
$25.43B
Net income
$21.04B
Gross margin
67.8%
Net margin
21.8%
Johnson & Johnson's net margin has decreased by 24% from the previous quarter and by 11% YoY
Johnson & Johnson's net income has decreased by 22% QoQ and by 3.5% YoY
The operating income rose by 21% year-on-year
Johnson & Johnson's operating margin has increased by 12% YoY

Price vs fundamentals

How does JNJ's price correlate with its fundamentals

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
JNJ P/E details
P/E
26.66
P/B
6.91
P/S
5.82
EV/EBIT
22.85
EV/EBITDA
17.61
EV/Sales
6.16
JNJ's price to earnings (P/E) is 34% higher than its last 4 quarters average of 19.9 and 25% higher than its 5-year quarterly average of 21.3
The EPS has contracted by 22% from the previous quarter and by 3.6% YoY
JNJ's price to book (P/B) is 21% more than its 5-year quarterly average of 5.7 and 17% more than its last 4 quarters average of 5.9
JNJ's equity is up by 3.9% year-on-year
The price to sales (P/S) is 16% more than the 5-year quarterly average of 5.0 and 16% more than the last 4 quarters average of 5.0
JNJ's revenue is up by 8% year-on-year and by 2.3% since the previous quarter

Efficiency

How efficient is Johnson & Johnson business performance
Johnson & Johnson's return on invested capital has decreased by 25% QoQ and by 22% YoY
The ROS has contracted by 24% from the previous quarter and by 12% YoY
The return on assets has declined by 22% since the previous quarter and by 10% year-on-year
The company's return on equity fell by 22% QoQ and by 12% YoY

Dividends

What is JNJ's dividend history
Dividend details
DPS
$5.24
Dividend yield
2.25%
Payout ratio
60%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 68% greater than its total liabilities
The quick ratio has decreased by 28% YoY
JNJ's current ratio is down by 18% year-on-year
Johnson & Johnson's debt is 32% less than its equity
Johnson & Johnson's debt has increased by 15% from the previous quarter and by 5% YoY
The company's debt to equity rose by 15% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.